Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JHX
JHX logo

JHX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy James Hardie Industries PLC (JHX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
21.370
1 Day change
6.42%
52 Week Range
29.820
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

James Hardie Industries PLC (JHX) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has seen hedge fund interest and some positive analyst sentiment, the recent financial performance shows declining net income, EPS, and gross margin. Additionally, technical indicators and options data do not suggest a clear upward momentum. Given the investor's preference for long-term stability, it would be prudent to wait for stronger financial performance or clearer bullish signals before investing.

Technical Analysis

The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 49.242, and moving averages are converging, showing no clear trend. The stock is trading near its pivot point of 19.898, with resistance at 21.18 and support at 18.616. Overall, the technical indicators suggest a lack of strong directional momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market, but the overall volume and open interest are not significant enough to drive a strong conclusion.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
6

Positive Catalysts

  • Hedge funds are increasing their positions, with a 224.32% increase in buying over the last quarter. Some analysts, such as JPMorgan, have upgraded the stock with optimistic growth projections for fiscal 2027 and 2028.

Neutral/Negative Catalysts

  • Additionally, the stock trend analysis predicts a potential decline of -2.92% in the next week and -5.53% in the next month.

Financial Performance

In Q3 2026, revenue increased by 30.05% YoY to $1.2398 billion. However, net income dropped by -51.52% YoY to $68.7 million, EPS fell by -63.64% YoY to $0.12, and gross margin decreased by -4.92% YoY to 36.15%. These declines indicate profitability challenges despite revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views. JPMorgan upgraded the stock to Overweight with a price target of A$41.50, citing strong fiscal Q3 results and optimistic growth projections. However, Barclays recently lowered its price target to $22, expressing concerns about the homebuilding sector in 2026. The overall sentiment is cautiously optimistic but not overwhelmingly bullish.

Wall Street analysts forecast JHX stock price to rise
6 Analyst Rating
Wall Street analysts forecast JHX stock price to rise
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 20.080
sliders
Low
21
Averages
24.5
High
30
Current: 20.080
sliders
Low
21
Averages
24.5
High
30
Barclays
Equal Weight
downgrade
$26 -> $22
AI Analysis
2026-04-08
Reason
Barclays
Price Target
$26 -> $22
AI Analysis
2026-04-08
downgrade
Equal Weight
Reason
Barclays lowered the firm's price target on James Hardie to $22 from $26 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the homebuilding and building products space as part of a Q1 earnings preview. Barclays favors building products and distributor names with pricing power and/or vertical integration. Investors should continue to avoid homebuilders as 2026 "shapes up to be a potential lost year," the analyst tells investors in a research note.
Barclays
Matthew Bouley
Equal Weight
maintain
$21 -> $26
2026-02-12
Reason
Barclays
Matthew Bouley
Price Target
$21 -> $26
2026-02-12
maintain
Equal Weight
Reason
Barclays analyst Matthew Bouley raised the firm's price target on James Hardie to $26 from $21 and keeps an Equal Weight rating on the shares. The company a strong fiscal Q3 beat with a "seemingly conservative" Q4 outlook, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JHX
Unlock Now

People Also Watch